Development of artificial endocrine organs composed of cultured skin cells
由培养的皮肤细胞组成的人工内分泌器官的开发
基本信息
- 批准号:09557096
- 负责人:
- 金额:$ 7.36万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A purpose of this study was to develop artificial endocrine organs by introducing genes of hormones or cytokines into human epidermal keratinocytes.(1) To increase infectivity of a retrovirus vectorwe constructed an adenovirus vector into which gene of an amphotropic retrovirus receptor is cloned. Although infectivity of a retrovirus vector to K562 cells were increased, infectivity to human epidermal keratinocytes was not changed after infection of the adenovirus.(2) We constructed a retrovirus vector into which both enhanced green fluorescent protein (GFP) gene and human preproinsulin cDNA were cloned. After infection of the retrovirus vector, GFP positive human epidermal keratinocytes were selected by FACS sorting. The procedure enriched GFP positive keratinocytes to10 times. These GFP positive cells stably produced proinsulin for 14 days in vitro. Although, when the cells were transplanted into immunodeficient mice, expression of both GFP and proinsulin were despaired within 4 weeks … More .(3) GFP and preproinsulin genes were cloned into MSCV retrovirus vector, which had altered LTR sequence. To measure the stability of introduced genes in vivo, human keratinocytes were infected by the vector and transplanted into immunodeficient mice. However, expression of the introduced genes could not be detected at 4 weeks after transplantation(4) A replication-defective vesicular stomatitis virus glycoprotein G pseudotyped HIV-1-based vector encoding the enhanced GFP was used for gene transfer into human keratinocytes. Afier infection of the lentiviral vector, 10% of the cells showed GFP positive.These results showed that enrichment of gene introduced cells using GFP marker and FACS sorting was a useful procedure for human keratinocytes. However, two major problems of conventional recombinant retrovirus vectors, low infectivity and unstable expression of introduced gene in vivo, were still remained. We considered that HIV-1 based lentiviral vector was a promising alternative for efficient and stable gene transfer into human epidermal keratinocytes. Less
本研究的目的是通过将激素或细胞因子的基因导入人表皮角质形成细胞来构建人工内分泌器官。(1)为了提高逆转录病毒载体的感染性,我们构建了一个腺病毒载体,其中克隆了嗜异性逆转录病毒受体基因。尽管逆转录病毒载体对K562细胞的感染性增加,但腺病毒感染后对人表皮角质形成细胞的感染性没有改变。(2)我们构建了一个逆转录病毒载体,其中同时克隆了增强型绿色荧光蛋白(GFP)基因和人前胰岛素原cDNA。感染逆转录病毒载体后,通过FACS分选选择GFP阳性的人表皮角质形成细胞。该程序将GFP阳性角质形成细胞富集至10倍。这些GFP阳性细胞在体外稳定产生胰岛素原14天。尽管如此,当将细胞移植到免疫缺陷小鼠中时,GFP和胰岛素原的表达在4周内均消失 ...更多信息 . (3)将GFP和前胰岛素原基因克隆到改变了LTR序列的MSCV逆转录病毒载体中。为了测量引入的基因在体内的稳定性,用载体感染人角质形成细胞并移植到免疫缺陷小鼠中。然而,在移植后4周不能检测到导入基因的表达(4)使用编码增强的GFP的复制缺陷型水泡性口炎病毒糖蛋白G假型HIV-1基载体将基因转移到人角质形成细胞中。转染慢病毒载体后,10%的细胞显示GFP阳性,表明用GFP标记和流式细胞仪分选富集基因导入细胞是一种有效的方法。然而,传统的重组逆转录病毒载体仍然存在感染性差和导入基因在体内表达不稳定两个主要问题。我们认为,基于HIV-1的慢病毒载体是一个有前途的替代高效和稳定的基因转移到人表皮角质形成细胞。少
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shimizu-T ; Ando-K ; Kimura-M ; Miyatake-H ; Inokuchi-S ; Takakura-I ; Migita-M ; Shimada-T ; Kato-S: "A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker."Acta-Paediatr-Jpn.. Dec : 40 (6).
清水-T ;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takayama M, Kim E, Kidokoro M, Shimamura K, Shiroki K, Yajima H, Kosukegawa, Handa H, Inokuchi S: "Transfer of SV40 temperature-sensitive early gene into human epidermal keratinocytes by the recombinant adenovirus vector"In-Vitro-Cell-Dev-Biol. Feb : 36 (
Takayama M、Kim E、Kidokoro M、Shimamura K、Shiroki K、Yajima H、Kosukekawa、Handa H、Inokuchi S:“通过重组腺病毒载体将 SV40 温度敏感早期基因转移到人表皮角质形成细胞中”In-Vitro-Cell
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shimizu T et al.: "A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker."Acta-Paediatr-Jpn.. 40. 586-92 (1998)
Shimizu T 等人:“通过使用绿色荧光蛋白基因作为选择标记来简单有效地纯化转导细胞。”Acta-Paediatr-Jpn.. 40. 586-92 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
猪口貞樹: "SCID・疾患モデル研究"日本医学館. 148 (1997)
Sadaki Inoguchi:“SCID/疾病模型研究”日本医学博物馆 148 (1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
takayama M et al.: "Transfer of SV40 temperature-sensitive early gene into human epidermal keratinocytes by the recombinant adenovirus vector."In-Vitro-Cell-Dev-Biol. 36. 110-6 (2000)
takayama M 等人:“通过重组腺病毒载体将 SV40 温度敏感早期基因转移到人表皮角质形成细胞中。”In-Vitro-Cell-Dev-Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
INOKUCHI Sadaki其他文献
INOKUCHI Sadaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('INOKUCHI Sadaki', 18)}}的其他基金
Development of cultured skin which has tolerance in ischemia.
培养具有缺血耐受性的皮肤的发育。
- 批准号:
15K10036 - 财政年份:2015
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Introduction of humanβ-defensin-3 and human cathelicidine antimicrobial peptide-18 into cultured human skin cells
将人β-defensin-3和人cathelicidine抗菌肽-18引入培养的人皮肤细胞中
- 批准号:
20591534 - 财政年份:2008
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of Hybrid Artificial Liver with Immortalized Human Hepatocytes
永生化人肝细胞混合人工肝的构建
- 批准号:
12671175 - 财政年份:2000
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Artificial endocrine organ composed of cultured human skin cells.
由培养的人体皮肤细胞组成的人工内分泌器官。
- 批准号:
07671334 - 财政年份:1995
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Melanocyte function of wound healing and its clinical application using cell sheet mixed with melanocytes and keratinocytes
黑素细胞的伤口愈合功能及其与黑素细胞和角质形成细胞混合的细胞片层的临床应用
- 批准号:
23K09092 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidating the effects of "human hair bacteria that regulate gene expression in keratinocytes" on hair growth
阐明“调节角质形成细胞基因表达的人类毛发细菌”对毛发生长的影响
- 批准号:
23KJ1710 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for JSPS Fellows
C/EBPβ Regulation of the Type 1 IFN Response; Sensitizing Keratinocytes to Direct Activators of Cytosolic PRRs and DNA Damage-Induced Cell Death
C/EBPβ 1 型干扰素反应的调节;
- 批准号:
10735531 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
The role of caspase recruitment domain-mediated signaling in keratinocytes during the immune response against leishmaniasis.
在针对利什曼病的免疫反应过程中,角质形成细胞中半胱天冬酶募集结构域介导的信号传导的作用。
- 批准号:
23K19484 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Epidermal keratinocytes mediate mechanical pain following neuropathic injury
表皮角质形成细胞介导神经性损伤后的机械性疼痛
- 批准号:
10387370 - 财政年份:2022
- 资助金额:
$ 7.36万 - 项目类别:
Identification of an endogenous AhR ligand and charcetrization of its mode of action
内源性 AhR 配体的鉴定及其作用模式的表征
- 批准号:
22K19402 - 财政年份:2022
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Role of neurokinin 1 receptor signaling in keratinocytes in allergic contact dermatitis
角质形成细胞中神经激肽 1 受体信号传导在过敏性接触性皮炎中的作用
- 批准号:
10581825 - 财政年份:2022
- 资助金额:
$ 7.36万 - 项目类别:
Regulation of melanin contents in keratinocytes
角质形成细胞中黑色素含量的调节
- 批准号:
22K06128 - 财政年份:2022
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Revealing the role of cellular microRNAs in human papillomavirus (HPV) replication in oral keratinocytes
揭示细胞 microRNA 在口腔角质细胞中人乳头瘤病毒 (HPV) 复制中的作用
- 批准号:
2742577 - 财政年份:2022
- 资助金额:
$ 7.36万 - 项目类别:
Studentship
In vitro study of the association between ALDH2 rs671 polymorphism and Acral Lentiginous Melanoma
ALDH2 rs671多态性与肢端雀斑样黑色素瘤关联的体外研究
- 批准号:
22K21117 - 财政年份:2022
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Research Activity Start-up